May, 07 2026 Thursday 15:24 Hrs
Last update 11-9-2025
  • SENSEX :   77,781.09

  • Top commodity trading and broking companies in India-177.43( -0.23%) 07-May-2026
Sensex 77797.94 -160.58  (-0.21) 07-May-2026
Previous Day Close 77958.52
Today's High/Low
High Low
  •  
  •  
78384.7 77713.21

Company News Details

Lupin Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500257
INE326A01037
595.4470362
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
LUPIN
20.19
111668.12
EPS(TTM)
Face Value()
Div & Yield %
120.94
2
0.49
 

Lupin Ltd
Lupin launches diabetes drug in U.S. after FDA nod
Apr 22,2026
The product is bioequivalent to Xigduo XR and will be marketed for the same indications as per the approved labeling.

Dapagliflozin and Metformin Hydrochloride is a combination medication used to improve glycemic control in adults with type 2 diabetes

Lupin is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. It specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients.

The pharmaceutical company reported a 37.46% surge in consolidated net profit to Rs 1,175.55 crore in Q3 FY26 as against Rs 855.16 crore posted in Q3 FY25. Total revenue from operations jumped 24.26% year-on-year to Rs 7,167.52 crore in the quarter ended 31 December 2025.

The counter shed 0.10% to end at Rs 2,309.45 on the BSE.

Top

Attention Investor:

Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers/Depository Participant.     KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, ,Mutual ).    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.